A new study reveals that dapagliflozin, a common diabetes medication, could significantly improve conditions like metabolic ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

NASH becomes MASH as medical experts replace stigmatizing "non-alcoholic" liver disease terminology with dignity-focused ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Modern unhealthy lifestyles and dietary habits have led to a yearly increase in the incidence of metabolism-related liver ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

New technology and drugs are transforming how doctors detect and treat silent liver disease MASLD before it leads to liver ...